Recovering from a stroke is rarely a straight line. Some functions return quickly, others take months, and some changes may be permanent. This page explains how post-stroke recovery is typically assessed, what standard rehabilitation involves in Malaysia, and what current stem cell research can and cannot show, so you have a realistic, informed picture before requesting an assessment.
Symptoms and Diagnosis
Post-stroke effects, often called sequelae, vary enormously depending on which part of the brain was affected and how quickly treatment was received.
| Common Post-Stroke Effect | Description |
| Motor weakness | Weakness or paralysis, often on one side of the body |
| Speech and language difficulty | Aphasia (difficulty with language) or dysarthria (difficulty with speech articulation) |
| Cognitive changes | Memory, attention, or problem-solving difficulties |
| Emotional changes | Post-stroke depression, anxiety, or emotional lability |
| Swallowing difficulty | Dysphagia, which affects eating and nutrition safety |
| Spasticity | Muscle stiffness or tightness that develops over time |
Assessment of post-stroke status typically involves:
- Neurological examination, assessing motor, sensory, speech, and cognitive function
- Imaging review, such as MRI or CT, to understand the extent and location of brain injury
- Standardised functional scales, such as the modified Rankin Scale, assessing overall disability level
- Specialist assessments, including physiotherapy, occupational therapy, and speech therapy evaluations
How much time has passed since the stroke matters significantly. The window from a few weeks to around 6 months post-stroke is generally considered the period of most active neuroplasticity-driven recovery, though meaningful improvement can continue beyond this in many patients.
Standard Care for Post-Stroke Recovery
Rehabilitation-led care remains the evidence-based foundation for stroke recovery, focused on maximising function through structured, consistent therapy.
| Approach | Purpose |
| Physiotherapy | Rebuilding strength, balance, and motor function |
| Occupational therapy | Supporting daily living skills and functional independence |
| Speech and language therapy | Addressing communication and swallowing difficulties |
| Secondary prevention | Blood pressure, cholesterol, and blood sugar control to reduce risk of further stroke |
| Psychological support | Addressing post-stroke depression and emotional adjustment |
| Spasticity management | Including medication, therapy, and in some cases targeted injections |
This rehabilitation pathway, ideally started early and sustained consistently, remains the cornerstone of stroke recovery, and any discussion of stem cell therapy should be understood as a potential addition to, not a replacement for, this standard approach.
What Current Research Can and Cannot Show
Stem cell research in stroke recovery is an active field exploring whether cell-based therapies can support the brain’s natural repair processes.
What current research suggests:
- Early-phase trials have explored MSC administration’s safety and feasibility in both acute and chronic stroke patients
- Proposed mechanisms generally centre on paracrine signalling, reducing inflammation, and supporting a more favourable environment for the brain’s own neuroplasticity, rather than replacing lost neurons directly
- Some studies have reported modest improvements on functional scales in treated groups, though findings are inconsistent across the field
What current evidence does not establish:
- No regulatory authority has approved stem cell therapy as a standard treatment for stroke recovery
- There is no guarantee of neurological recovery, and current evidence does not reliably predict which patients, if any, might respond
- Most published trials remain small and early-phase, with efficacy data still accumulating
- Long-term functional outcome data beyond 1 to 2 years remains limited
At 23C Regen, any discussion of post-stroke care is grounded in this evidence picture. We do not promise neurological recovery or claim to replace the role of structured rehabilitation. An assessment is about reviewing your specific situation honestly.
Risks and Exclusions
General risks associated with MSC administration can include:
- Infusion-related reactions
- Rare allergic or immune responses
- The importance of coordinating closely with your treating neurologist given the complexity of post-stroke medical management
Patients who may be excluded from assessment or treatment can include those with:
- Acute, unstable stroke requiring urgent hospital-based management
- Active malignancy, pending oncology clearance
- Significant uncontrolled bleeding risk or anticoagulation complexity
- Active, untreated infection
- Other unstable medical conditions requiring priority management
Assessment Records You’ll Need
- Neurologist’s notes and stroke diagnosis details, including stroke type and affected brain region
- Recent imaging reports (MRI/CT)
- Current rehabilitation records, including therapy progress notes if available
- A list of current medications, particularly anticoagulants or antiplatelets
- Functional assessment scores, if previously documented
Follow-Up
Stroke recovery is an ongoing, often long-term process. Our approach includes:
- A clear explanation of your current status and realistic considerations following assessment
- Honest guidance on whether stem cell therapy is reasonable to discuss further for your specific situation
- Coordination notes you can share with your treating neurologist and rehabilitation team
- Scheduled review points if you proceed with treatment, alongside continued standard rehabilitation
Questions to Discuss During Your Assessment
- How long has it been since my stroke, and how does that affect my realistic options?
- What does current evidence actually show for someone at my recovery stage?
- Will this replace or interrupt my current rehabilitation programme?
- What are the risks given my specific stroke type and overall health?
- How will any response to treatment actually be measured?
Understanding Your Recovery Timeline Before Your Assessment
Where you are in the recovery timeline significantly shapes which considerations are realistic to discuss, so it’s worth understanding broadly what each phase typically involves before your visit.
| Phase | General Timeframe | Typical Focus |
| Acute phase | First few days to weeks | Medical stabilisation, early mobilisation under hospital or rehabilitation team care |
| Subacute phase | Weeks to around 6 months | Period of most active neuroplasticity-driven recovery; intensive therapy typically most impactful here |
| Chronic phase | Beyond 6 months | Continued, often slower gains possible with sustained therapy; different considerations apply |
This isn’t a rigid cutoff, meaningful improvement can continue well beyond 6 months for many patients with consistent rehabilitation, but it does affect how realistic expectations and any additional treatment discussion should be framed.
Why a Documented Assessment Matters More Than a General Opinion
Post-stroke status varies enormously between individuals, even with similar-sounding diagnoses, depending on which brain regions were affected, stroke severity, and overall health. A general conversation about symptoms, without reviewing your actual imaging, neurological assessment, and current rehabilitation progress, cannot responsibly determine whether any additional treatment is appropriate to discuss. This is why we ask for documented records before any specific recommendation.
Frequently Asked Questions
Can stem cell therapy reverse paralysis after a stroke?
No. Current evidence does not reliably demonstrate reversal of paralysis, and no treatment can currently guarantee specific neurological recovery outcomes.
Will this replace my physiotherapy or rehabilitation programme?
No. Any assessment at 23C Regen is intended to sit alongside, not replace, your ongoing rehabilitation with your treating therapy team.
Is it too late if my stroke happened years ago?
Research includes patients at various recovery stages, though evidence for chronic-stage treatment remains early. Discuss your specific timeline during assessment.
What type of stem cells are used for stroke-related assessment?
We use laboratory-cultured Wharton’s Jelly-derived mesenchymal stem cells. Your doctor will explain the specific protocol considered for your case.
Do I need my neurologist’s referral before booking an assessment?
A referral isn’t required, but bringing your neurologist’s notes and imaging helps us provide a more accurate, informed assessment.
What happens if I’m found unsuitable for treatment?
You’ll receive an honest explanation, with guidance on continuing your rehabilitation and standard neurological care.
Request a Post-Stroke Assessment
If you’d like an honest conversation about your post-stroke recovery and what current research can realistically offer, request an assessment. Review our full list of treatable conditions beforehand.